Publication | Closed Access

Bupropion: A new antidepressant drug, the mechanism of action of which is not associated with down-regulation of postsynaptic β-adrenergic, serotonergic (5-HT2), α2-adrenergic, imipramine and dopaminergic receptors in brain

Molecular PharmacologyDopaminergic ReceptorsNew Antidepressant DrugNeurophysiologyMedicinePsychotropic MedicationPsychopharmacologyNeuropharmacologySocial SciencesPharmacotherapyNeuroscienceNeurologyBiological PsychiatryDopaminePharmacologyInhibitory Neurotransmitters